Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes

Clinical trial NCT00976495 · COMPLETED

Trial details

NCT number: NCT00976495
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2009-10-01
Primary completion: 2010-11-01
Enrollment: 154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.